In this study, we explored the mechanism of chemoresistance from the perspective of chemotherapy-induced ER stress, screened out EDEM1 as a crucial regulator of DOX-induced ER stress, verified its role in promoting breast cancer progression and DOX resistance, and proved its prognostic value in breast cancer (Fig. 8). The gene discussed is EDEM1; the disease is breast cancer.